AAV8介导的对氧磷酶1变体基因治疗可对小鼠提供针对神经毒剂的长期预防性保护
该研究采用AAV8载体递送对氧磷酶1变体PON1-IF11,使小鼠肝脏表达并分泌毫克级重组蛋白。单次注射后,小鼠对多种致死剂量G型神经毒剂(塔崩、沙林、环沙林、梭曼)获得无症状预防性保护,持续长达5个月,血液学与血清生化指标未见毒性征象。
要点
- 单次AAV8-PON1-IF11注射可使小鼠表达毫克级循环PON1-IF11蛋白
- 小鼠对塔崩、沙林、环沙林、梭曼多倍致死剂量获得无症状保护达5个月
- 血液学与血清生化指标未见临床毒性征象
核心结论
- AAV8介导的PON1-IF11基因治疗单次给药可对小鼠提供针对多种G型化学战神经毒剂的长期无症状预防性保护。
研究设计与样本
- 研究采用AAV8载体递送PON1-IF11基因的基因治疗策略,在小鼠中评估对G型神经毒剂的预防性保护效果。
主要发现
- 单次注射肝特异性AAV8-PON1-IF11颗粒后,小鼠表达并分泌毫克级重组PON1-IF11。
- 重组PON1-IF11在体外和啮齿类体内可将G型化学战神经毒剂分解为生物无活性产物。
- 小鼠对塔崩、沙林、环沙林和梭曼的多倍致死剂量获得无症状保护,持续长达5个月。
- 血液中毫克浓度重组PON1-IF11的小鼠,其血液学参数与血清生化谱未见临床毒性征象。
临床怎么用
- 该策略提示单次基因治疗应用可能表达接近天然的循环治疗性PON1-IF11蛋白,为人类提供数周至数月的G型神经毒剂预防性保护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chemical warfare nerve agents are organophosphorus chemical compounds that induce cholinergic crisis, leaving little or no time for medical intervention to prevent death. The current chemical treatment regimen may prevent death but does not prevent postexposure complications such as brain damage and permanent behavioral abnormalities. In the present study, we have demonstrated an adeno-associated virus 8 (AAV8)-mediated paraoxonase 1 variant IF-11 (PON1-IF11) gene therapy that offers asymptomatic prophylactic protection to mice against multiple lethal doses of G-type chemical warfare nerve agents, namely, tabun, sarin, cyclosarin, and soman, for up to 5 months in mice. A single injection of liver-specific adeno-associated viral particles loaded with PON1-IF11 gene resulted in expression and secretion of recombinant PON1-IF11 in milligram quantities, which has the catalytic power to break down G-type chemical warfare nerve agents into biologically inactive products in vitro and in vivo in rodents. Mice containing milligram concentrations of recombinant PON1-IF11 in their blood displayed no clinical signs of toxicity, as judged by their hematological parameters and serum chemistry profiles. Our study unfolds avenues to develop a one-time application of gene therapy to express a near-natural and circulating therapeutic PON1-IF11 protein that can potentially protect humans against G-type chemical warfare nerve agents for several weeks to months.
引用
- Betapudi V, Goswami R, Silayeva L, et al. Gene therapy delivering a paraoxonase 1 variant offers long-term prophylactic protection against nerve agents in mice. Sci Transl Med. 2020. PMID: 31969483. doi:10.1126/scitranslmed.aay0356
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。